Warning: The NCBI web site requires JavaScript to function. more...
Prospective monitoring improves outcomes of primary total hip replacement: a cohort study.
Streubel PN, Pachón M, Kerguelén CA, Navas J, Portocarrero J, Pesantez RF, Zayed G, Carrillo G, Llinás AM.
Patient Saf Surg. 2009 Apr 14;3(1):7.
Related citations
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.
Health Technol Assess. 2006 Apr;10(11):1-110. Review.
Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal.
Holmes M, Carroll C, Papaioannou D.
Health Technol Assess. 2009 Sep;13 Suppl 2:55-62. Review.
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P, De Groote K, Annemans L.
Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. Epub 2004 Sep 10.
Assessment of health-related quality of life after surgical treatment of focal symptomatic spinal stenosis compared with osteoarthritis of the hip or knee.
Rampersaud YR, Ravi B, Lewis SJ, Stas V, Barron R, Davey R, Mahomed N.
Spine J. 2008 Mar-Apr;8(2):296-304. Epub 2007 Jun 18.
Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
Gerkens S, Beguin C, Crott R, Closon MC, Horsmans Y.
J Eval Clin Pract. 2008 Aug;14(4):585-94. Epub 2008 May 2.
Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C, Mouret P.
Semin Vasc Med. 2005 Aug;5(3):266-75. Review.
Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
Douketis JD, Eikelboom JW, Quinlan DJ, Willan AR, Crowther MA.
Arch Intern Med. 2002 Jul 8;162(13):1465-71.
A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI, Gómez-Outes A, Martínez-González J, Rocha E; Bemiparin 6 Hours After Surgery Study Group.
Arch Orthop Trauma Surg. 2007 Oct;127(8):665-70. Epub 2006 Nov 7.
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.
Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.
J Thromb Haemost. 2003 Oct;1(10):2119-30.
Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
Bullano MF, Willey V, Hauch O, Wygant G, Spyropoulos AC, Hoffman L.
J Manag Care Pharm. 2005 Oct;11(8):663-73.
A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
Altavela JL, Jones MK, Ritter M.
J Manag Care Pharm. 2008 Nov-Dec;14(9):831-43.
Epidural analgesia for pain relief following hip or knee replacement.
Choi PT, Bhandari M, Scott J, Douketis J.
Cochrane Database Syst Rev. 2003;(3):CD003071. Review.
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
Eikelboom JW, Quinlan DJ, Douketis JD.
Lancet. 2001 Jul 7;358(9275):9-15.
Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.
Samama CM, Vray M, Barré J, Fiessinger JN, Rosencher N, Lecompte T, Potron G, Basile J, Hull R, Desmichels D; SACRE Study Investigators.
Arch Intern Med. 2002 Oct 28;162(19):2191-6.
An evaluation of practice pattern for venous thromboembolism prevention in Lebanese hospitals.
Zeitoun AA, Dimassi HI, El Kary DY, Akel MG.
J Thromb Thrombolysis. 2009 Aug;28(2):192-9. Epub 2008 Dec 27.
Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty.
Anderson DR, Wilson SJ, Blundell J, Petrie D, Leighton R, Stanish W, Alexander D, Robinson KS, Burton E, Gross M.
J Bone Joint Surg Am. 2002 Nov;84-A(11):1992-7.
Patient ethnicity and use of venous thromboembolism prophylaxis.
Gelber RP, Seto TB.
Int J Qual Health Care. 2006 Feb;18(1):23-9. Epub 2005 Aug 22.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on